GL1X · GenesisL1 explorer

MolNFT v1 · #118831 · protein

Crystal structure of human pcaf bromodomain in complex with compound BDOMB00091A (compound 14)

5FDZ · Histone acetyltransferase KAT2B: “Crystal structure of human pcaf bromodomain in complex with compound BDOMB00091A (compound 14)”. X-ray diffraction, 1 ligand (5X0), 3 pockets (best druggability 0.62). MolNFT v1 #118831 on…

PDB
5FDZ
Type
protein
Length
213 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase KAT2B
EC
2.3.1.48
UniProt
Q92831
Ligands
5X0
Pockets
3 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase KAT2B (EC 2.3.1.48)protein10766% helix, 0% strandQ92831
BHistone acetyltransferase KAT2B (EC 2.3.1.48)protein10666% helix, 0% strandQ92831

Ligands and binding sites

  • 5X0 · ~{N}-methyl-2-(oxan-4-yloxy)-5-(2-oxidanylidene-2-phenylazanyl-ethoxy)benzamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14090.620.7748empty
21100.520.82215X0
3990.490.81195X0

Interfaces

1 interface between chains.

  • A–B · 709 Ų buried · 8 hydrogen bonds · protein-protein

Compared structures

  • 5FDZ · Crystal structure of human PCAF bromodomain in complex with compound BDOMB00091a… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92831 · AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT2B (Q92831) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.